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Mary Ellen Avery’s research is recognized as a milestone in biomedical research. She had
discovered the underlying cause of hyaline membrane disease, surfactant deficiency, fos-
tering ever more vigorous efforts to reduce neonatal mortality in the burgeoning practice
of Neonatology. Neonatology is the only clinical discipline that began as an experiment,
making it a model for biomedical research. Avery knew that the concerted effort to treat
preterm newborns could potentially do more harm than good, violating her oath to Hip-
pocrates, if not held to the highest scientific standards. She remained true to that pledge
throughout her career, as recounted in this Review.
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INTRODUCTION
I feel like the narrator recounting his tale at the wedding banquet
in Coleridge’s epic poem “The Rime of the Ancient Mariner.” Of
course anyone can go to PubMed and retrieve Mary Ellen Avery’s
publications, totaling 146 peer-reviewed papers, but the back story
is what I am going to relate, largely based on my personal recall
under her tutelage for 25 years.
Her interest in the breathing problems of newborn infants had
been piqued by the awareness that the most common finding in
the lungs of premature infants born alive who died shortly there-
after, was atelectasis and hyaline membranes. The pathology had
been well-described by both George Anderson and Peter Gru-
enwald at Johns Hopkins. They both emphasized the lack of a
clinical description of the course of the disease. In 1947, Gruen-
wald (1) described the unusual expansion patterns of the lungs of
premature infants. He hypothesized that an unusually high surface
tension could account for the high pressure necessary to introduce
air into the lungs, but also that air was trapped in the lungs in a
Swiss cheese-like pattern, as predicted by the Law of LaPlace.
Richard Pattle (2) was studying the foam of pulmonary edema
in the Chemical Defense Establishment in Porton, England, since
some gases used in wartime such as phosgene induce lung edema,
so antidotes were being sought. The unusual stability of bubbles
expressed from normal lungs led Pattle to conclude that the inter-
nal surface of the lung must be covered with a lining layer of very
low surface tension. He suggested that absence of the lining sub-
stance of the alveoli might play a role in causing atelectasis. The
appearance of hyaline membranes might be due to a defective
lining layer causing transudation from the blood, or to excessive
secretion of the lining substance itself.
Dr. Avery had completed her pediatric residency at Johns Hop-
kins in the 1950s, so she went off to Boston to study respiratory
physiology at the Harvard School of Public Health with Jere Mead,
in conjunction with a Fellowship to study newborn infants with
Clement Smith at the Boston Lying-In Hospital.
Mead’s laboratory had discovered that if the lung was filled
with air it had greater elastic recoil than if it were filled with saline,
leading to the realization that the surface forces of the lung, which
are greater at an air–liquid interface than at a liquid–liquid inter-
face, caused the elastic recoil of the lung. Mead’s group used these
observations to calculate lung surface area, which differed substan-
tially from that estimated by the morphologists. That observation
prompted Clements to measure the surface tension of material
expressed from the lung. Clements, tried to reconcile the Mead
laboratory data with Pattle’s findings of stable bubbles expressed
from lungs having zero surface tension. Whittenberger at the Har-
vard School of Public Health, a research advisor to Clements at
Edgewood Arsenal, Maryland communicated Clements’ findings
to Mead and Avery back in Boston. Clements had reasoned that a
dynamic method of measurement of surface tension would better
reflect conditions in the lung, so he designed a modified Wil-
helmy surface film balance to study changes in surface tension with
area. His striking observation established the important feature of
the alveolar lining layer, namely a change in surface tension with
area, so that at large lung volumes surface tension is high, and at
low lung volumes it approaches zero. He named the material pre-
sumed to be at the alveolar–air interface “pulmonary surfactant,”
and commented on its central role as an anti-atelectatic factor.
Avery visited Clements’ lab at the Edgewood Arsenal in Decem-
ber, 1957 to see the surface film balance. On her return to Boston,
Mead proposed a way to modify the method to allow them to study
minced extracts from lungs of human infants. Samples of lungs
were obtained courtesy of Kurt Benirshke, the chief of pathol-
ogy at the Boston Lying-In Hospital at that time. The absence of
foam in the lungs at autopsy was a prominent observation that
might have led to the conclusion that these lungs were deficient
www.frontiersin.org April 2014 | Volume 2 | Article 34 | 1
Torday Mary Ellen Avery’s research career
FIGURE 1 |The Joint Program in Neonatology (JPN), 1984, in front of the
Administration Building (Building C), Harvard Medical School. In 1984, on
the 25th anniversary of the publication of the Avery and Mead paper,
members of the Joint Program in Neonatology, which Dr. Avery had created in
1974, gathered for a group picture with her in front of the administration
building at Harvard Medical School. Those in attendance were clinicians,
clinician-scientists, and basic scientists alike as the embodiment of Dr.
Avery’s eternal effort “to do no harm.”
in surfactant even in the absence of measurements on the sur-
face film balance. The first measurements were made before Pattle
had published his observations in 1958. His finding that the bub-
bles expressed from lungs of immature guinea pigs were unstable
reassured Avery that she was on the right track in her stud-
ies of the lungs of infants who had died of hyaline membrane
disease (HMD).
There were multiple theories for the pathogenesis of HMD
when Avery began her study of lung surfactant. In the first edi-
tion of her book The Lung and its Disorders in the Newborn Infant
(3), she objectively presented what was known at the time, and,
although she presented observations on the possible role of surface
forces, she admitted that the etiology of HMD was unknown. She
recapped the arguments for the primacy of aspiration, asphyxia,
heart failure, shock, disturbed autonomic regulation, fibrinolytic
enzyme defect, prolonged acid–base derangements, and low serum
proteins. Over the ensuing years these variables have been elim-
inated one by one, bringing ever-greater clarity to the ultimate
role of surfactant deficiency. The first time Avery unequivocally
stated that HMD was due to surfactant deficiency was in the fourth
edition of her textbook in 1981.
RESPIRATORY DISTRESS SYNDROME AS SURFACTANT
DEFICIENCY – EVIDENCE-BASED MEDICINE
The first four peer-reviewed papers Avery published were case
reports, beginning in 1955 (4). But then there was that watershed
year of 1959 when she and Jere Mead published their ground-
breaking paper on HMD as surfactant deficiency (5). She would
tell her students how difficult it was to publish this manuscript
because it went against convention – Hochheim had declared that
HMD was an obstructive disease due to the eosinophilic mem-
branes found in the airways of the newborns who had died of this
disease. But Avery was aware of the studies done by Von Neergaard
and Pattle, showing that there was surface tension reducing activ-
ity in the alveoli of the mammalian lung. She reasoned that if these
infants were surfactant deficient that that would have accounted
for the atelectasis and exudation of fluid across the alveolar wall,
producing the hyaline membranes. If she was right, there was an
opportunity to correct the disease, in contrast to the assumed
intrauterine obstructive mechanism associated with HMD. From
that point forward Dr. Avery published another 141 papers, but of
those there were 26 that would plot her arc as the clinician-scientist
who conquered HMD. I would like to recount those studies within
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the context of Dr. Avery’s effort to validate HMD as Respiratory
Distress Syndrome, or surfactant deficiency disease. In early stud-
ies excised lungs of human newborns were used (6) in tandem
with animal models to establish the relationship between surfac-
tant and lung function (7), and the expression of lamellar bodies
in alveolar type II cells as a function of development (8). And
since the functional surfactant was predicated on its secretion by
the alveolar type II cell, an elegant histologic study was published
demonstrating this property of the alveolar epithelium (9). In a
series of follow-up studies, Avery and her colleagues demonstrated
relationships between conventional knowledge of pulmonary alve-
olar homeostasis and lung surfactant at the cellular, functional,
and pathophysiologic levels (10–15) to further convince the sci-
entific community of the mechanistic relevance of the surfactant
system to alveolar homeostasis. Subsequent studies were designed
to try and identify factors that might accelerate the appearance
and activity of surfactant in order to prevent RDS (15), including
observations that hormonal acceleration of lung maturation was
physiologic in nature (16). Such studies were done in conjunction
with the further elucidation of those factors that merely caused res-
piratory distress, such as edema (17) and retained fetal lung fluid
(18), versus those that specifically caused RDS as surfactant defi-
ciency disease, strictly defined as dependence on oxygen support
in association with grunting, flaring, and retracting of the thorax,
and a ground-glass appearance of the lung on x-ray examination.
The breakthrough in the treatment of surfactant deficiency
in utero came when Liggins discovered that antenatal gluco-
corticoids could accelerate lung maturation. Avery’s laboratory
performed a systematic series of studies to demonstrate the phys-
iologic effect of glucocorticoids on lung surfactant production in
both rabbits (19–23) and lambs (24), including untoward effects
like the inhibition of lung growth (25) for “full disclosure” – Avery
wanted her colleagues to be totally informed about this emerg-
ing therapy. Subsequent studies filled in gaps in the relationships
between physiologic and pathophysiologic agents and surfactant
dynamics (26, 27) so as to further elaborate on the basic and clin-
ical aspects of surfactant biology for the scientific community.
Among these was the study by Wyszogrodski (28) showing that
beta adrenergic agents caused surfactant secretion, an important
observation for both basic and clinical understanding of surfac-
tant’s properties. The last scientific peer-reviewed paper that was
co-authored by Dr. Avery was the demonstration of the sexual
dimorphism in the rate of lung maturation during human fetal
development (29), capping a series of animal studies conducted in
my laboratory with Heber C. Nielsen. Those studies were designed
to determine why males were not as responsive to antenatal glu-
cocorticoids as females, an observation first reported by Kotas and
Avery (30).
In 1984, on the 25th anniversary of the publication of the Avery
and Mead paper, members of the Joint Program in Neonatology,
which Dr. Avery had created in 1974, gathered for a group picture
with her in front of the Administration Building at Harvard Med-
ical School (see Figure 1). Those in attendance were clinicians,
clinician-scientists, and basic scientists alike as the embodiment
of Dr. Avery’s eternal effort “to do no harm.”
In addition to her research efforts, Dr. Avery was a champion
for women in the field of medicine. Along with Lynn Reid and
Mary Ellen Wohl, she strongly advocated for a level playing field
as the first woman ever to have become the Chair of a clinical
department at Harvard Medical School. When she was applying
to medical school she was rejected by Harvard Medical School
because of their policy of excluding women – always the student
of history, fighting the hard fight for what was right despite the
prevailing attitudes, whether in science or social justice.
Dr. Avery’s last cited paper, entitled “What is good for children
is good for mankind: the role of imagination in discovery” was
her formal Address to the American Association for the Advance-
ment of Science as the President of the society in the year 2004
(31). In her speech, she emphasized the power of the imagination
to overcome mankind’s problems. She certainly demonstrated her
own ability to achieve that goal, and even surpassed it through her
leadership and mentoring.
I can only hope that her spirit will marshal on.
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